中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共8条，第1-8条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
NIR-II nano fluorescence image guided hepatic carcinoma resection on cirrhotic patient 期刊论文
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2022, 卷号: 40, 页码: 3
作者:  Zhang, Zeyu;  Fang, Cheng;  Zhang, Yang;  Su, Song;  Li, Bo;  Liu, Gang;  Hu, Zhenhua;  Tian, Jie
收藏  |  浏览/下载：238/0  |  提交时间：2022/11/14
NIR-II fluorescence imaging  Hepatic carcinoma (HCC)  Cirrhosis  Image-guided surgery  Nano probe  
Patient-Level Prediction of Multi-Classification Task at Prostate MRI Based on End-to-End Framework Learning From Diagnostic Logic of Radiologists 期刊论文
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2021, 卷号: 68, 期号: 12, 页码: 3690-3700
作者:  Shao, Lizhi;  Liu, Zhenyu;  Yan, Ye;  Liu, Jiangang;  Ye, Xiongjun;  Xia, Haizhui;  Zhu, Xuehua;  Zhang, Yuting;  Zhang, Zhiying;  Chen, Huiying;  He, Wei;  Liu, Cheng;  Lu, Min;  Huang, Yi;  Sun, Kai;  Zhou, Xuezhi;  Yang, Guanyu;  Lu, Jian;  Tian, Jie
收藏  |  浏览/下载：277/0  |  提交时间：2021/12/28
Magnetic resonance imaging  Principal component analysis  Pathology  Lesions  Optimization  Task analysis  Predictive models  Gleason score  prostate cancer  patient-level prediction  joint optimization  MRI  reinforcement learning  
In vivo multifunctional fluorescence imaging using liposome-coated lanthanide nanoparticles in near-infrared-II/IIa/IIb windows 期刊论文
NANO TODAY, 2021, 卷号: 38, 页码: 11
作者:  Yang, Junying;  He, Shuqing;  Hu, Zhenhua;  Zhang, Zeyu;  Cao, Caiguang;  Cheng, Zhen;  Fang, Chihua;  Tian, Jie
收藏  |  浏览/下载：206/0  |  提交时间：2021/08/15
NIR-II  IIa  IIb windows  Fluorescence imaging  Brown adipose tissue  Multifunctional nanoprobe  Rare-earth-doped nanoparticle  Excretory capacity  
Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsy 期刊论文
THERANOSTICS, 2020, 卷号: 10, 期号: 22, 页码: 10200-10212
作者:  Shao, Lizhi;  Yan, Ye;  Liu, Zhenyu;  Ye, Xiongjun;  Xia, Haizhui;  Zhu, Xuehua;  Zhang, Yuting;  Zhang, Zhiying;  Chen, Huiying;  He, Wei;  Liu, Cheng;  Lu, Min;  Huang, Yi;  Ma, Lulin;  Sun, Kai;  Zhou, Xuezhi;  Yang, Guanyu;  Lu, Jian;  Tian, Jie
收藏  |  浏览/下载：247/0  |  提交时间：2021/03/02
prostate cancer  Gleason grade groups  deep reinforcement learning  prostate cancer grading  magnetic resonance imaging  
First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows 期刊论文
NATURE BIOMEDICAL ENGINEERING, 2019, 卷号: 4, 期号: 3, 页码: 16
作者:  Hu, Zhenhua;  Fang, Cheng;  Li, Bo;  Zhang, Zeyu;  Cao, Caiguang;  Cai, Meishan;  Su, Song;  Sun, Xingwang;  Shi, Xiaojing;  Li, Cong;  Zhou, Tiejun;  Zhang, Yuanxue;  Chi, Chongwei;  He, Pan;  Xia, Xianming;  Chen, Yue;  Gambhir, Sanjiv Sam;  Cheng, Zhen;  Tian, Jie
Adobe PDF(2918Kb)  |  收藏  |  浏览/下载：455/88  |  提交时间：2020/03/30
A Non-invasive Radiomic Method Using F-18-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With Glioma 期刊论文
FRONTIERS IN ONCOLOGY, 2019, 卷号: 9, 页码: 11
作者:  Li, Longfei;  Mu, Wei;  Wang, Yaning;  Liu, Zhenyu;  Liu, Zehua;  Wang, Yu;  Ma, Wenbin;  Kong, Ziren;  Wang, Shuo;  Zhou, Xuezhi;  Wei, Wei;  Cheng, Xin;  Lin, Yusong;  Tian, Jie
收藏  |  浏览/下载：296/0  |  提交时间：2020/03/30
F-18-FDG PET  radiomics  glioma  isocitrate dehydrogenase  non-invasive prediction  
Radiomics signature based on FDG-PET predicts proliferative activity in primary glioma 期刊论文
CLINICAL RADIOLOGY, 2019, 卷号: 74, 期号: 10, 页码: 9
作者:  Kong, Z.;  Li, J.;  Liu, Zehua;  Liu, Zhenyu;  Zhao, D.;  Cheng, X.;  Li, L.;  Lin, Y.;  Wang, Y.;  Tian, J.;  Ma, W.
收藏  |  浏览/下载：293/0  |  提交时间：2019/12/16
F-18-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma 期刊论文
CANCER IMAGING, 2019, 卷号: 19, 期号: 1, 页码: 10
作者:  Kong, Ziren;  Lin, Yusong;  Jiang, Chendan;  Li, Longfei;  Liu, Zehua;  Wang, Yuekun;  Dai, Congxin;  Liu, Delin;  Qin, Xuying;  Wang, Yu;  Liu, Zhenyu;  Cheng, Xin;  Tian, Jie;  Ma, Wenbin
收藏  |  浏览/下载：256/0  |  提交时间：2019/12/16
Radiomics  FDG PET  MGMT promoter methylation  Glioma  Prognosis